CytoDyn (QB) Stock Price - CYDY

2.96
0.14 (4.96%)
2.96
Best deals to access real time data!
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
Small Cap Pro
Monthly Subscription
for only
$49.05
Canna Trader Pro
Monthly Subscription
for only
$59.99
VAT not included
Company Name Stock Ticker Symbol Market Type
CytoDyn Inc (QB) CYDY OTCMarkets Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.14 4.96% 2.96 2.83 2.98 2.83 2.82 16:27:36
Bid Price Ask Price Spread Spread % News
2.95 2.98 0.03 1.01% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
2,194 1,921,013 $ 2.9336 $ 5,635,521 6,858,552 0.261 - 3.86
Last Trade Time Type Quantity Stock Price Currency
16:05:22 formt 20,000 $ 2.95 USD

CytoDyn (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.52B 514.73M 302.11M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
9.54M $ - 0.00% - -

more financials information »

CytoDyn (QB) News

Date Time Source News Article
5/15/202008:47Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)
5/12/202006:00Edgar (US Regulatory)Notice of Effectiveness (effect)
4/30/202017:28Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)
4/28/202017:29Edgar (US Regulatory)Current Report Filing (8-k)
4/27/202017:03Edgar (US Regulatory)Current Report Filing (8-k)
4/23/202017:08Edgar (US Regulatory)Current Report Filing (8-k)
4/22/202019:35Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CYDY Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week3.173.242.783.024,727,321-0.21-6.62%
1 Month3.503.692.533.055,261,578-0.54-15.43%
3 Months1.053.860.812.677,429,3221.91181.9%
6 Months0.283.860.2612.115,346,3322.68957.14%
1 Year0.3953.860.2611.932,910,9252.57649.37%
3 Years0.6053.860.05521.711,164,9762.36389.26%
5 Years0.9453.860.05521.61786,7982.02213.23%

CytoDyn (QB) Description

CytoDyn Inc. is a late-stage biotechnology company developing innovative treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor. Leronlimab is in a class of therapeutic monoclonal antibodies designed to address unmet medical needs in the areas of Human Immunodeficiency Virus (HIV), Cancer, and Immunology.
Your Recent History
USOTC
CYDY
CytoDyn (Q..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200601 03:06:00